Adaptive Biotechnologies Corp
ADPT
71 insider filings · Latest: Oct 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Mar 14 12:55 AM | Sharon BenzenoChief Commercial Ofc Imm Med | Sale | 63,103 | $13.17 | $831.1K | 272,751(D) | View → |
| Mar 11, 2026 | Mar 14 12:52 AM | Kyle PiskelChief Financial Officer | Sale | 18,672 | $13.17 | $245.9K | 259,840(D) | View → |
| Mar 11, 2026 | Mar 14 12:49 AM | Harlan S RobinsChief Scientific Officer | Sale | 470,266 | $13.17 | $6.2M | 1,522,058(D) | View → |
| Mar 11, 2026 | Mar 14 12:45 AM | Chad M RobinsDirector, CEO and Chairman | Sale | 470,167 | $13.17 | $6.2M | 2,301,113(D) | View → |
| Mar 11, 2026 | Mar 11 8:42 PM | FRANCIS LO | Proposed Sale | 30,593 | $14.52 | $444.2K | — | View → |
| Mar 11, 2026 | Mar 11 8:21 PM | MICHELLE GRIFFIN | Proposed Sale | 15,394 | $13.91 | $214.1K | — | View → |
| Mar 10, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Sale | 19,460 | $14.68 | $285.7K | 643,471(D) | View → |
| Mar 9, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Sale | 30,941 | $14.79 | $457.6K | 647,809(D) | View → |
| Mar 6, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Sale | 30,941 | $15.14 | $468.4K | 652,147(D) | View → |
| Mar 5, 2026 | Mar 10 11:53 PM | LO FRANCIS | Proposed Sale | 38,074 | $16.44 | $625.9K | — | View → |
| Mar 5, 2026 | Mar 10 12:29 AM | Francis LOChief People Officer | Sale | 38,074 | $15.09 | $574.5K | 321,967(D) | View → |
| Mar 3, 2026 | Mar 6 1:05 AM | Michelle Renee GriffinDirector | Sale | 48,044 | $15.30 | $735.1K | 15,394(D) | View → |
| Mar 5, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Sale | 30,941 | $16.00 | $495.1K | 575,235(D) | View → |
| Mar 4, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Sale | 30,941 | $16.60 | $513.6K | 579,573(D) | View → |
| Mar 3, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Sale | 30,941 | $15.67 | $484.8K | 583,911(D) | View → |
| Mar 3, 2026 | Mar 5 12:58 AM | Harlan S RobinsChief Scientific Officer | Sale | 14,233 | $16.52 | $235.1K | 1,155,291(D) | View → |
| Mar 2, 2026 | Mar 5 12:58 AM | Harlan S RobinsChief Scientific Officer | Sale | 10,000 | $15.72 | $157.2K | 1,169,524(D) | View → |
| Mar 3, 2026 | Mar 4 12:51 AM | Chad M RobinsDirector, CEO and Chairman | Sale | 53,083 | $15.52 | $823.8K | 1,934,247(D) | View → |
| Mar 2, 2026 | Mar 4 12:51 AM | Chad M RobinsDirector, CEO and Chairman | Sale | 289,024 | $15.82 | $4.6M | 1,987,330(D) | View → |
| Feb 27, 2026 | Mar 4 12:51 AM | Chad M RobinsDirector, CEO and Chairman | Sale | 182,891 | $15.99 | $2.9M | 2,276,354(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Oct 16 11:21 PM | Julie RubinsteinPresident and COO | Option Exercise | 11,881 | $12.14 | 237,205(D) | View → |
| Oct 15, 2026 | Oct 16 11:21 PM | Julie RubinsteinPresident and COO | Option Exercise | 11,881 | $12.14 | 249,086(D) | View → |
| Oct 14, 2026 | Oct 16 11:21 PM | Julie RubinsteinPresident and COO | Option Exercise | 11,881 | $12.14 | 260,967(D) | View → |
| Oct 13, 2026 | Oct 13 11:05 PM | Julie RubinsteinPresident and COO | Option Exercise | 11,881 | $12.14 | 272,848(D) | View → |
| Oct 12, 2026 | Oct 13 11:05 PM | Julie RubinsteinPresident and COO | Option Exercise | 11,881 | $12.14 | 284,729(D) | View → |
| Oct 9, 2026 | Oct 13 11:05 PM | Julie RubinsteinPresident and COO | Option Exercise | 11,881 | $12.14 | 296,610(D) | View → |
| Oct 8, 2026 | Oct 8 10:54 PM | Julie RubinsteinPresident and COO | Option Exercise | 11,881 | $12.14 | 308,491(D) | View → |
| Oct 7, 2026 | Oct 8 10:54 PM | Julie RubinsteinPresident and COO | Option Exercise | 11,881 | $12.14 | 320,372(D) | View → |
| Oct 6, 2026 | Oct 8 10:54 PM | Julie RubinsteinPresident and COO | Option Exercise | 11,881 | $12.14 | 332,253(D) | View → |
| Oct 5, 2026 | Oct 6 12:15 AM | Julie RubinsteinPresident and COO | Option Exercise | 11,881 | $12.14 | 344,134(D) | View → |
| Oct 2, 2026 | Oct 6 12:15 AM | Julie RubinsteinPresident and COO | Option Exercise | 11,881 | $12.14 | 356,015(D) | View → |
| Oct 1, 2026 | Oct 6 12:15 AM | Julie RubinsteinPresident and COO | Option Exercise | 11,881 | $12.14 | 367,896(D) | View → |
| Oct 1, 2026 | Oct 6 12:12 AM | Francis LOChief People Officer | Option Exercise | 26,792 | $8.46 | 93,765(D) | View → |
| Sep 16, 2026 | Sep 19 12:17 AM | Francis LOChief People Officer | Option Exercise | 105,560 | $12.14 | 103,142(D) | View → |
| Aug 18, 2026 | Aug 20 9:55 PM | Robert HershbergDirector | Option Exercise | 15,000 | $6.32 | 0(D) | View → |
| Aug 18, 2026 | Aug 20 12:15 AM | Chad M RobinsDirector, CEO and Chairman | Option Exercise | 278,676 | $6.55 | 0(D) | View → |
| Aug 17, 2026 | Aug 20 12:15 AM | Chad M RobinsDirector, CEO and Chairman | Option Exercise | 321,324 | $6.55 | 278,676(D) | View → |
| Aug 17, 2026 | Aug 20 12:07 AM | Peter M NeupertDirector | Option Exercise | 15,000 | $6.32 | 0(D) | View → |
| Jul 21, 2026 | Jul 23 11:34 PM | Harlan S RobinsChief Scientific Officer | Option Exercise | 284,800 | $6.55 | 0(D) | View → |
| Jul 15, 2026 | Jul 17 11:23 PM | Francis LOChief People Officer | Option Exercise | 105,762 | $12.14 | 37,511(D) | View → |
Page 1 of 4
Next →